nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—PPARG—brown adipose tissue—hypothyroidism	0.185	0.22	CbGeAlD
Balsalazide—ALOX5—heart—hypothyroidism	0.0399	0.0475	CbGeAlD
Balsalazide—ALOX5—cardiovascular system—hypothyroidism	0.0377	0.0448	CbGeAlD
Balsalazide—PPARG—heart—hypothyroidism	0.03	0.0356	CbGeAlD
Balsalazide—ALOX5—adrenal gland—hypothyroidism	0.0298	0.0354	CbGeAlD
Balsalazide—ALOX5—blood—hypothyroidism	0.0298	0.0354	CbGeAlD
Balsalazide—ALOX5—thyroid gland—hypothyroidism	0.0287	0.0342	CbGeAlD
Balsalazide—PPARG—cardiovascular system—hypothyroidism	0.0283	0.0336	CbGeAlD
Balsalazide—ALOX5—female gonad—hypothyroidism	0.0278	0.033	CbGeAlD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0258	0.163	CbGpPWpGaD
Balsalazide—ALOX5—testis—hypothyroidism	0.0246	0.0293	CbGeAlD
Balsalazide—ALOX5—liver—hypothyroidism	0.0233	0.0277	CbGeAlD
Balsalazide—ALOX5—cerebellum—hypothyroidism	0.0228	0.0271	CbGeAlD
Balsalazide—PPARG—adrenal gland—hypothyroidism	0.0224	0.0266	CbGeAlD
Balsalazide—PPARG—blood—hypothyroidism	0.0224	0.0266	CbGeAlD
Balsalazide—PPARG—thyroid gland—hypothyroidism	0.0216	0.0257	CbGeAlD
Balsalazide—PPARG—female gonad—hypothyroidism	0.0209	0.0248	CbGeAlD
Balsalazide—PPARG—Nuclear Receptors—THRA—hypothyroidism	0.0191	0.12	CbGpPWpGaD
Balsalazide—PPARG—testis—hypothyroidism	0.0185	0.022	CbGeAlD
Balsalazide—PPARG—liver—hypothyroidism	0.0175	0.0208	CbGeAlD
Balsalazide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0166	0.105	CbGpPWpGaD
Balsalazide—PTGS1—heart—hypothyroidism	0.016	0.019	CbGeAlD
Balsalazide—PTGS2—adrenal cortex—hypothyroidism	0.0158	0.0188	CbGeAlD
Balsalazide—PTGS2—heart—hypothyroidism	0.0153	0.0182	CbGeAlD
Balsalazide—PTGS1—cardiovascular system—hypothyroidism	0.0151	0.018	CbGeAlD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0151	0.0949	CbGpPWpGaD
Balsalazide—PTGS2—cardiovascular system—hypothyroidism	0.0144	0.0172	CbGeAlD
Balsalazide—PTGS1—pituitary gland—hypothyroidism	0.0134	0.0159	CbGeAlD
Balsalazide—PTGS2—pituitary gland—hypothyroidism	0.0128	0.0152	CbGeAlD
Balsalazide—PPARG—Nuclear Receptors—THRB—hypothyroidism	0.0123	0.0774	CbGpPWpGaD
Balsalazide—PTGS1—adrenal gland—hypothyroidism	0.012	0.0142	CbGeAlD
Balsalazide—PTGS1—blood—hypothyroidism	0.012	0.0142	CbGeAlD
Balsalazide—PTGS1—thyroid gland—hypothyroidism	0.0115	0.0137	CbGeAlD
Balsalazide—PTGS2—adrenal gland—hypothyroidism	0.0114	0.0136	CbGeAlD
Balsalazide—PTGS2—blood—hypothyroidism	0.0114	0.0136	CbGeAlD
Balsalazide—PTGS1—female gonad—hypothyroidism	0.0111	0.0133	CbGeAlD
Balsalazide—PTGS2—female gonad—hypothyroidism	0.0107	0.0127	CbGeAlD
Balsalazide—PTGS1—testis—hypothyroidism	0.00989	0.0118	CbGeAlD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00971	0.0611	CbGpPWpGaD
Balsalazide—PTGS2—liver—hypothyroidism	0.00894	0.0106	CbGeAlD
Balsalazide—PTGS2—cerebellum—hypothyroidism	0.00873	0.0104	CbGeAlD
Balsalazide—PPARG—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.00479	0.0301	CbGpPWpGaD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00465	0.0292	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00404	0.0254	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00369	0.0232	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—NKX2-1—hypothyroidism	0.0034	0.0214	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—THRA—hypothyroidism	0.0026	0.0164	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ZNF764—hypothyroidism	0.00195	0.0122	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00185	0.0117	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—IYD—hypothyroidism	0.00185	0.0117	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—THRB—hypothyroidism	0.00168	0.0106	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—ATP5O—hypothyroidism	0.00157	0.00991	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—TPO—hypothyroidism	0.00148	0.00932	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—CLTC—hypothyroidism	0.00138	0.00872	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00137	0.00863	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—AVP—hypothyroidism	0.00129	0.00813	CbGpPWpGaD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00128	0.00807	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—THRA—hypothyroidism	0.00125	0.00789	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—IGF1—hypothyroidism	0.00117	0.00736	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—IYD—hypothyroidism	0.00115	0.00722	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—ATP5O—hypothyroidism	0.000975	0.00614	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—TPO—hypothyroidism	0.000916	0.00577	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—NKX2-5—hypothyroidism	0.000893	0.00562	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000849	0.00534	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—THRB—hypothyroidism	0.000808	0.00508	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—IYD—hypothyroidism	0.000803	0.00505	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—TSHB—hypothyroidism	0.000685	0.00431	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—ATP5O—hypothyroidism	0.000683	0.0043	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—POMC—hypothyroidism	0.000681	0.00428	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—VAV3—hypothyroidism	0.000652	0.00411	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—TPO—hypothyroidism	0.000642	0.00404	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—IYD—hypothyroidism	0.000637	0.00401	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PIK3C2A—hypothyroidism	0.000611	0.00385	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000603	0.00379	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000595	0.00374	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—ATP5O—hypothyroidism	0.000542	0.00341	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—SLC5A5—hypothyroidism	0.000513	0.00323	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—TPO—hypothyroidism	0.00051	0.00321	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000478	0.00301	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000472	0.00297	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—TSHB—hypothyroidism	0.000424	0.00267	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PIK3C2A—hypothyroidism	0.000378	0.00238	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000373	0.00235	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—SLC5A5—hypothyroidism	0.000318	0.002	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—TSHB—hypothyroidism	0.000297	0.00187	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—POMC—hypothyroidism	0.000268	0.00169	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PIK3C2A—hypothyroidism	0.000265	0.00167	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000261	0.00165	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—TSHB—hypothyroidism	0.000236	0.00149	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—SLC5A5—hypothyroidism	0.000222	0.0014	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—PIK3C2A—hypothyroidism	0.00021	0.00132	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000207	0.00131	CbGpPWpGaD
Balsalazide—PTGS2—Disease—PRL—hypothyroidism	0.000186	0.00117	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—SLC5A5—hypothyroidism	0.000177	0.00111	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—POMC—hypothyroidism	0.000166	0.00105	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—POMC—hypothyroidism	0.000116	0.000733	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—POMC—hypothyroidism	9.24e-05	0.000582	CbGpPWpGaD
